Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 020926
Company: GENZYME
Company: GENZYME
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
RENAGEL | SEVELAMER HYDROCHLORIDE | 403MG | CAPSULE;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
10/30/1998 | ORIG-1 | Approval | Type 1 - New Molecular Entity | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20926lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/20926ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/020926.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
02/06/2004 | SUPPL-6 | Efficacy-Labeling Change With Clinical Data |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20926se1-006,21179se1-002ltr.pdf |
08/08/2002 | SUPPL-5 | Manufacturing (CMC) |
Label is not available on this site. |
||
03/15/2002 | SUPPL-4 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
10/13/2000 | SUPPL-3 | Manufacturing (CMC) |
Label is not available on this site. |
||
05/05/2000 | SUPPL-2 | Efficacy-New Dosing Regimen |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/20926S2LTR.PDF |
10/01/1999 | SUPPL-1 | Manufacturing (CMC) |
Label is not available on this site. |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
10/30/1998 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20926lbl.pdf |